在细胞性甲状腺癌中,巨细胞的丰富性与PD-L1表达有关
Julio C Ricarte-Filho1, Caitlin O Caperton2, Amber Isaza1
1Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Endocrine oncology (Bristol, England)
|October 13, 2025
概括
卵巢癌是一种复杂的疾病,有不同的亚型. 这项研究确定了囊性甲状腺癌 (OTC) 和卵泡性甲状腺癌 (FTC) 之间的关键分子和免疫差异,揭示了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤细胞性甲状腺癌 (OTC) 是甲状腺癌的一个独特的亚型,具有攻击性特征.
- 以前与卵泡性甲状腺癌 (FTC) 组合在一起,OTC具有独特的基因病理和分子特征.
- OTC经常表现出对放射性治疗 (RAI) 的耐药性,并且具有更高的转移潜力.
研究的目的:
- 为了比较OTC和FTC的转录形状和免疫细胞种群.
- 确定OTC和FTC之间基因表达特征和免疫细胞透的关键差异.
- 基于分子和免疫分析,探索OTC的潜在治疗策略.
主要方法:
- 使用向RNA测序对转录特征进行比较分析.
- 通过多重免疫组织化学评估免疫细胞组成.
- 通过免疫染评估PD-L1和CD68的表达.
主要成果:
- 与非新发性甲状腺组织相比,OTC表现出高调代谢通路基因和低调细胞因子-细胞因子受体通路基因.
- 与FTC相比,OTC显示甲状腺分化基因的表达减少.
- 在OTC中观察到CD274/PD-L1的上调,与瘤细胞衍生的PD-L1和CD68+巨细胞存在相关,特别是在广泛侵入性的病例中.
结论:
- 较高的代谢活性和较低的OTC分化与临床特征相关,如FDG-PET狂热和较差的RAI反应.
- 在广泛侵入性的OTC中显著的PD-L1上调表明免疫检查点抑制的潜在有效性.
- 需要在更大规模的独立研究中进一步验证,以确认这些发现及其治疗影响.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.0K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.9K
相关概念视频
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K